♪ [music] ♪ My name is Chris Waddling, I'm a field application scientist with SPT Labtech. I'm based in San Francisco, and my territory is across the country. Behind me is the Dynamic Duo. It's a combination of our mosquito High Volume and our dragonfly discovery.
The mosquito is a low-volume pipetting robot that works between 0.5 microliter and 5 microliters, and really we use it to miniaturize our NGS workflows. We have over 40 workflows that we have pre-validated on this system, and the dragonfly is a compliment to that. So, if we're doing higher throughputs, the dragonfly is a great bulk dispenser that allows us to really ramp up our throughput.
The mosquito and dragonfly both use our true-positive displacement technology and so for pipetting things from beads to reagents, we don't have to do any kind of liquid class settings. So that's one of the major benefits of the machine. We can get down to really low volumes, and we can really help people scale up into higher throughput, so using 384-well plates in all of these. The dragonfly can dispense up to the full volume of the syringe, which is 4 milliliters, but it can also go down as low as 200 nanoliters.
So, you have this huge dynamic range of volumes you can dispense, and it allows you to really push the limits of your research. Right now we have them everywhere. They're in NGS labs across the country and across the world, biotechs, pharma, and academia and so we see this combination of these two machines in all of that. The great thing about the dragonfly and the mosquito is they're really agnostic to application and so both machines could be used independently or they can be used together in other workflows as well.
So, you can put the dragonfly in a lab and someone can come up and use it for something else. Even beyond the NGS labs we find people are going to be using the dragonfly. I see the future of these machines being in every lab that's doing testing, that's doing surveillance testing for other diseases besides COVID. During COVID times we were using these machines quite a bit and labs were using these machines a lot to do their testing because they were able to miniaturize, because reagents were scarce, and they needed to find a way to do more with less.
And so as we move forward, we're looking at other diseases, other viruses that are going to come out and we need a way to tackle them quickly and efficiently and in a cost-effective way.
.jpg)
.jpg)
